novo nordisk weight loss - Search News

News

Novo Nordisk to Replace C.E.O.

CNBC on MSN · 14h

Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly

Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish drugmaker last week abruptly announced that longtime CEO Lars Fruergaard Jørgensen is stepping down,

The New York Times · 3d

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Associated Press News on MSN · 3d

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

Pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the company's board of directors, citing “recent market challenges” and a steep decline in the company's share price.

3don MSN

Novo Nordisk ousts CEO after falling behind in weight loss drug market

Jorgensen, who has been CEO since 2017, will remain in the role until a new CEO has been appointed, Novo Nordisk said ...

3d

Novo Nordisk, U.S. biotech company team up to create obesity pills

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

6d

Why Weight-Loss Developer Stocks Tumbled on Tuesday

A pronouncement from President Trump about the category drove their share prices down, although not to bargain-basement ...

3d

Novo Nordisk CEO's surprise exit after setbacks in weight-loss market: Reaction

Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results